Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Bader, Michael Prof. Dr. (16) Bähring, Sylvia Dr. (4) Birchmeier, Walter Prof. Dr. (9) Birchmeier-Kohler, Carmen Prof. Dr. (4) Blankenstein, Thomas Prof. Dr. (9) Dechend, Ralf Priv. Doz. (5) Falcke, Martin Prof. Dr. (4) Falk, Kirsten Dr. (1) Fielitz, Jens Dr. (1) Forslund, Sofia Dr. (1) Gerhardt, Holger Prof. Dr. (4) Gorski, Stan Dr. (1) Gösele, Claudia Dr. (1) Gotthardt, Michael Prof. Dr. (3) Heinemann, Udo Prof. Dr. (6) Herse, Florian PD Dr. (1) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (3) Hübner, Norbert Prof. Dr. (6) Ivics, Zoltan Dr. (2) Izsvak, Zsuzsanna Dr. (2) Janke, Jürgen Dr. (4) Janz, Martin Dr. (3) Jarosch, Ernst Dr. (1) Jentsch, Thomas Prof. Dr. (4) Kammertöns, Thomas Dr. (1) Kempa, Stefan Dr. (2) Kettenmann, Helmut Prof. Dr. (10) Kettritz, Ralph Prof. Dr. (9) Kirsch, Frank-Peter Dr. (1) Klaassen, Sabine Prof. Dr. med. (1) Klußmann, Enno PD Dr. (4) Kopp, Joachim Dr. (1) Kowenz-Leutz, Elisabeth Dr. (1) Kühn, Ralf Dr. (5) Landthaler, Markus Prof. Dr. (1) Lee, Young-Ae Prof. Dr. (1) Leutz, Achim Prof. Dr. (3) Lewin, Gary Prof. Dr. (2) Luft, Friedrich Prof. Dr. (55) Mathas, Stephan Dr. (1) Morano, Ingo Prof. Dr. (7) Müller, Dominik Prof. Dr. (5) Müller, Gerd Dr. (5) Müller, Thomas Dr. (2) Na, Il-Kang Dr. (2) Niendorf, Thoralf Prof. Dr. (2) Obermayer-Wasserscheid, Benedikt Dr. (1) Perrot, Andreas (2) Pezzutto, Antonio Prof. Dr. (2) Pilz, Bernhard Dr. (4) Pischon, Tobias Prof. Dr. (4) Pombo, Ana Prof. Dr. (5) Popova, Elena Dr. (1) Poulet, James Prof. Dr. (3) Rajewsky, Klaus Prof. Dr. (1) Rajewsky, Nikolaus Prof. Dr. (3) Rathjen, Fritz Prof. Dr. (2) Rehm, Armin Dr. (1) Rocks, Oliver Dr. (1) Saar, Kathrin Dr. (3) Sander, Maike Prof. Dr. (4) Scheidereit, Claus Prof. Dr. (5) Schlag, Peter M. Prof. Dr. (31) Schlegel, Wolfgang-Peter (1) Schmitt, Clemens Prof. Dr. (3) Schreiber, Adrian PD Dr. med. (2) Schulz-Menger, Jeanette Prof. Dr. (4) Selbach, Matthias Prof. Dr. (1) Sommer, Thomas Prof. Dr. (1) Sperling, Silke Prof. Dr. (1) Stein, Ulrike Prof. Dr. (4) Tursun, Baris Dr. (1) Uckert, Wolfgang Prof. Dr. (5) Waiczies, Sonia PD Dr. (1) Wallukat, Gerd Dr. (9) Walther, Wolfgang Prof. Dr. (4) Wanker, Erich Prof. Dr. (6) Wellner, Maren Dr. (6) Wenzel, Katrin Dr. (2) Willnow, Thomas Prof. Dr. (7) Wolf, Jana Prof. Dr. (1) Zampieri, Niccolo Dr. (1) (-) Daniel, Peter Prof. Dr. (13) Translationale Onkologie solider Tumore (1) 1997 (1) 2001 (5) 2002 (6) (-) 2003 (13) 2004 (5) 2005 (18) 2006 (15) 2007 (5) 2008 (1) 2009 (8) 2010 (6) 2011 (8) 2012 (5) 2013 (7) 2014 (1) 2015 (4) 2016 (1) 2017 (6) 2018 (7) 2019 (6) 2020 (4) 2021 (4) 2022 (2) 2023 (4) 2024 (1) 13 Ergebnisse: Active Filter: Daniel, Peter Prof. Dr.2003 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 11. Dezember 2003 / Oncogene CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants J. Eberle L.F. Fecker A.M. Hossini T. Wieder P.T. Daniel C.E. Orfanos C.C. Geilen 11. Dezember 2003 / Oncogene Induction of apoptosis by enediyne antibiotic calicheamicin gammaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner A. Prokop W. Wrasidlo H. Lode R. Herold F. Lang G. Henze B. Doerken T. Wieder P.T. Daniel 27. November 2003 / Oncogene Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference C. Denkert A. Fuerstenberg P.T. Daniel I. Koch M. Koebel W. Weichert A. Siegert S. Hauptmann 01. Oktober 2003 / Essays Biochem Guardians of cell death: the Bcl-2 family proteins P.T. Daniel K. Schulze-Osthoff C. Belka D. Guener 15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel 01. September 2003 / Hum Gene Ther Adenoviral natural born killer gene therapy for malignant glioma U. Naumann F. Schmidt W. Wick B. Frank S. Weit B. Gillissen P. Daniel M. Weller 01. September 2003 / Curr Med Chem Anticancer Agents Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy D. Guener C. Belka P.T. Daniel 15. Juli 2003 / EMBO J Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway B. Gillissen F. Essmann V. Graupner L. Staerck S. Radetzki B. Doerken K. Schulze-Osthoff P.T. Daniel 01. April 2003 / Cell Death Differ Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability A. Mrozek H. Petrowsky I. Sturm J. Kraus S. Hermann S. Hauptmann M. Lorenz B. Doerken P.T. Daniel 01. April 2003 / Cell Death Differ Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy I. Sturm A.G. Bosanquet S. Hermann D. Guener B. Doerken P.T. Daniel Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
11. Dezember 2003 / Oncogene CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants J. Eberle L.F. Fecker A.M. Hossini T. Wieder P.T. Daniel C.E. Orfanos C.C. Geilen
11. Dezember 2003 / Oncogene Induction of apoptosis by enediyne antibiotic calicheamicin gammaII proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner A. Prokop W. Wrasidlo H. Lode R. Herold F. Lang G. Henze B. Doerken T. Wieder P.T. Daniel
27. November 2003 / Oncogene Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference C. Denkert A. Fuerstenberg P.T. Daniel I. Koch M. Koebel W. Weichert A. Siegert S. Hauptmann
01. Oktober 2003 / Essays Biochem Guardians of cell death: the Bcl-2 family proteins P.T. Daniel K. Schulze-Osthoff C. Belka D. Guener
15. September 2003 / J Clin Oncol Dynamic expression profile of p21 WAF1/CIP1 and Ki-67 predicts survival in rectal carcinoma treated with preoperative radiochemotherapy B. Rau I. Sturm H. Lage S. Berger U. Schneider S. Haupfmann P. Wust H. Riess P.M. Schlag B. Doerken P.T. Daniel
01. September 2003 / Hum Gene Ther Adenoviral natural born killer gene therapy for malignant glioma U. Naumann F. Schmidt W. Wick B. Frank S. Weit B. Gillissen P. Daniel M. Weller
01. September 2003 / Curr Med Chem Anticancer Agents Disruption of cell death signaling in cancer: impact on disease prognosis and response to therapy D. Guener C. Belka P.T. Daniel
15. Juli 2003 / EMBO J Induction of cell death by the BH3-only Bcl-2 homolog Nbk/Bik is mediated by an entirely Bax-dependent mitochondrial pathway B. Gillissen F. Essmann V. Graupner L. Staerck S. Radetzki B. Doerken K. Schulze-Osthoff P.T. Daniel
01. April 2003 / Cell Death Differ Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability A. Mrozek H. Petrowsky I. Sturm J. Kraus S. Hermann S. Hauptmann M. Lorenz B. Doerken P.T. Daniel
01. April 2003 / Cell Death Differ Mutation of p53 and consecutive selective drug resistance in B-CLL occurs as a consequence of prior DNA-damaging chemotherapy I. Sturm A.G. Bosanquet S. Hermann D. Guener B. Doerken P.T. Daniel